ROCKET PHARMACEUTICALS, INC. short interest in 2025
In 2025, ROCKET PHARMACEUTICALS, INC.'s disclosed short interest ran from 12.84% of shares outstanding on 15 Jan 2025 to 11.78% on 31 Dec 2025, a change of -1.06 percentage points. The year's high was 14.59% on 15 Apr 2025 and its low 10.19% on 28 Nov 2025, averaging 12.18% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.17 days on 14 Feb 2025. Full history: ROCKET PHARMACEUTICALS, INC..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 12.84% (15 Jan 2025)
- End of year
- 11.78% (31 Dec 2025)
- Change
- -1.06 pp
- High
- 14.59% (15 Apr 2025)
- Low
- 10.19% (28 Nov 2025)
- Average
- 12.18%
- Highest days to cover
- 9.17 (14 Feb 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 12.84% | 7.01 | |
| 31 Jan 2025 | 11.54% | 6.69 | |
| 14 Feb 2025 | 12.33% | 9.17 | |
| 28 Feb 2025 | 12.11% | 8.98 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 12.12% | 7.30 | |
| 31 Mar 2025 | 13.64% | 6.09 | |
| 15 Apr 2025 | 14.59% | 2.70 | |
| 30 Apr 2025 | 13.45% | 4.61 | |
| 15 May 2025 | 12.94% | 3.98 | 10-Q filed, results (8-K) |
| 30 May 2025 | 11.74% | 1.19 | |
| 13 Jun 2025 | 13.03% | 2.76 | |
| 30 Jun 2025 | 12.61% | 3.05 | |
| 15 Jul 2025 | 11.97% | 4.58 | |
| 31 Jul 2025 | 10.43% | 3.02 | |
| 15 Aug 2025 | 10.87% | 5.33 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 14.35% | 1.60 | |
| 15 Sep 2025 | 13.80% | 8.76 | |
| 30 Sep 2025 | 12.70% | 5.73 | |
| 15 Oct 2025 | 11.49% | 3.13 | |
| 31 Oct 2025 | 10.20% | 5.90 | |
| 14 Nov 2025 | 10.68% | 5.64 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 10.19% | 5.19 | |
| 15 Dec 2025 | 11.00% | 5.34 | |
| 31 Dec 2025 | 11.78% | 7.71 |
See also: ROCKET PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.